Introduction of histological classification and cytology reporting format of the Japanese General Rules for the Description of Thyroid Cancer with a special focus on the differences of the WHO Histological Classification and The Bethesda System of Thyroid Cytology.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
28 Jun 2021
Historique:
pubmed: 16 4 2021
medline: 15 12 2021
entrez: 15 4 2021
Statut: ppublish

Résumé

Histological classification and cytology reporting format described in General Rules for the Description of Thyroid Cancer, the 8

Identifiants

pubmed: 33853988
doi: 10.1507/endocrj.EJ21-0077
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-630

Auteurs

Atsuhiko Sakamoto (A)

Department of Pathology and Laboratory Medicine, Omori Red Cross Hospital, Tokyo 143-8527, Japan.
Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.

Mitsuyoshi Hirokawa (M)

Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.
Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe 650-0011, Japan.

Masahiro Ito (M)

Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.
Department of Pathology, NHO Nagasaki Medical Center, Nagasaki 856-8562, Japan.

Hiroshi Naganuma (H)

Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.
Department of Pathology, Sendai Red Cross Hospital, Sendai 982-0801, Japan.

Osamu Suzuki (O)

Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.
Department of Pathology, Fukushima Medical University, Fukushima 960-1259, Japan.

Yuko Hashimoto (Y)

Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.
Department of Pathology, Fukushima Medical University, Fukushima 960-1259, Japan.

Shinichi Suzuki (S)

Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.
Department of Thyroid and Endocrinology, Fukushima Medical University, Fukushima 960-1259, Japan.

Hiroki Shimura (H)

Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.
Department of Laboratory Medicine, Fukushima Medical University, Fukushima 960-1259, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH